Published in JAMA on July 15, 1998
Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ (1999) 5.45
What errors do peer reviewers detect, and does training improve their ability to detect them? J R Soc Med (2008) 4.92
Peer review of statistics in medical research: the other problem. BMJ (2002) 4.81
Effects of training on quality of peer review: randomised controlled trial. BMJ (2004) 4.20
Alternatives to peer review: novel approaches for research evaluation. Front Comput Neurosci (2011) 3.52
The relationship of previous training and experience of journal peer reviewers to subsequent review quality. PLoS Med (2007) 3.47
Evidence on peer review-scientific quality control or smokescreen? BMJ (1999) 1.85
Inter-rater agreement in the scoring of abstracts submitted to a primary care research conference. BMC Health Serv Res (2002) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study. BMJ (2014) 1.36
Effect of blinding and unmasking on the quality of peer review. J Gen Intern Med (1999) 1.21
Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis. BMC Med (2016) 1.01
Peer review in PLoS Medicine. PLoS Med (2007) 1.00
Peer Review Quality and Transparency of the Peer-Review Process in Open Access and Subscription Journals. PLoS One (2016) 0.95
Evidence based publishing. BMJ (2006) 0.93
Reviewing manuscripts for biomedical journals. Perm J (2010) 0.92
Peer review. J Community Hosp Intern Med Perspect (2012) 0.87
Manuscript rejection: how to submit a revision and tips on being a good peer reviewer. Plast Reconstr Surg (2014) 0.81
Recommendations for reviewing a manuscript for the GMS Zeitschrift für Medizinische Ausbildung. GMS Z Med Ausbild (2010) 0.81
Being critical and constructive: a guide to peer reviewing for librarians. J Med Libr Assoc (2017) 0.75
Emerging Themes in Epidemiology: Form and function. Emerg Themes Epidemiol (2004) 0.75
The ethics of peer review in bioethics. J Med Ethics (2013) 0.75
Reviewing the peer review. Indian J Pharmacol (2008) 0.75
The scholarship of critical review: improving quality and relevance. J Can Chiropr Assoc (2008) 0.75
Delayed decisions-how long is too long? J Hip Preserv Surg (2016) 0.75
The editorial process: Peer review. Can Urol Assoc J (2013) 0.75
Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study. BMJ Open (2015) 0.75
What makes the best medical ethics journal? A North American perspective. J Med Ethics (2005) 0.75
Entering the electronic age: risks and challenges for JGIM. J Gen Intern Med (2000) 0.75
Understanding the peer review process. World J Surg (2006) 0.75
[The responsibilities of reviewers and editors]. Schmerz (2017) 0.75
Why are doctors so unhappy? There are probably many causes, some of them deep. BMJ (2001) 22.59
Evidence based medicine. BMJ (1995) 21.24
What clinical information do doctors need? BMJ (1996) 16.23
Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90
Informed consent: the intricacies. BMJ (1997) 13.97
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
An ethical code for everybody in health care. BMJ (1998) 9.13
All changed, changed utterly. British medicine will be transformed by the Bristol case. BMJ (1998) 9.08
Growing pressure on BMJ's obituaries. BMJ (1995) 8.92
Authorship: time for a paradigm shift? BMJ (1997) 8.90
WHO in crisis. BMJ (1994) 8.82
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
The failings of NICE. BMJ (2000) 8.50
The future of medicine. BMJ (1994) 8.14
A good death. An important aim for health services and for us all. BMJ (2000) 8.03
Using evidence to inform health policy: case study. BMJ (2001) 7.99
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Time to face up to research misconduct. BMJ (1996) 7.66
Beyond conflict of interest. Transparency is the key. BMJ (1998) 7.63
Meeting the information needs of health workers in developing countries. BMJ (1997) 6.31
Medicine's core values. BMJ (1994) 5.93
Revel in electronic and paper media. BMJ (2000) 5.82
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
The GMC on performance. BMJ (1992) 5.57
Informed consent: edging forwards (and backwards) BMJ (1998) 5.52
PubMed Central: creating an Aladdin's cave of ideas. BMJ (2001) 5.49
Does Britain need an academy of medicine? BMJ (1996) 5.47
Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ (1999) 5.45
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Rationing: the search for sunlight. BMJ (1992) 5.26
Publishing information about patients. BMJ (1995) 5.19
The future of healthcare systems. BMJ (1997) 5.14
Prejudice against doctors and students from ethnic minorities. Br Med J (Clin Res Ed) (1987) 5.12
The war on drugs. BMJ (1996) 5.11
Global information flow. BMJ (2000) 5.09
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Where is the wisdom...? BMJ (1991) 4.85
Medicine and the marginalised. They deserve the best, not the poorest, care. BMJ (2000) 4.80
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. Biochemistry (1995) 4.64
Time to register randomised trials. The case is now unanswerable. BMJ (1999) 4.55
PFI: perfidious financial idiocy. A "free lunch" that could destroy the NHS. BMJ (1999) 4.54
Moving beyond journals: the future arrives with a crash. BMJ (1999) 4.49
Rationing: the debate we have to have. BMJ (1995) 4.47
Time to redefine authorship. BMJ (1996) 4.39
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Animal research: the need for a middle ground. BMJ (2001) 4.34
Conflict of interest and the BMJ. BMJ (1994) 4.34
Prison medicine: beginning again. BMJ (1992) 4.29
Measuring the social impact of research. BMJ (2001) 4.17
The case for structuring the discussion of scientific papers. BMJ (1999) 4.16
Peer review: reform or revolution? BMJ (1997) 4.13
Profile of the GMC: The day of judgment comes closer. BMJ (1989) 4.10
Managing the clinical performance of doctors. A coherent response to an intractable problem. BMJ (1999) 4.08
Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA (1998) 4.03
Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry (1999) 3.95
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92
Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89
Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell (1979) 3.78
Profile of the GMC. 1978 and all that. BMJ (1989) 3.76
"Taken from this place and hanged by the neck...". BMJ (1991) 3.72
The rights of patients in research. BMJ (1995) 3.68
All doctors are problem doctors. BMJ (1997) 3.67
The BMJ's website scales up. BMJ (1998) 3.67
Publishing research supported by the tobacco industry. BMJ (1996) 3.65
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
How best to organise acute hospital services? BMJ (2001) 3.63
Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61
Netprints: the next phase in the evolution of biomedical publishing. BMJ (1999) 3.60
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med (1999) 3.53
GMC: approaching the abyss. BMJ (2001) 3.52
The deliberate misdiagnosis of major depression in primary care. Arch Fam Med (1994) 3.46
Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this. BMJ (1999) 3.44
Don't treat shackled patients. BMJ (1997) 3.40
New government, same narrow vision. BMJ (1998) 3.40
The woolwich and erith project. Planning a community health service. Lancet (1966) 3.34
Almost no evidence exists that the internet harms health. BMJ (2001) 3.31
Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell (1979) 3.26
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr (1990) 3.24
The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22
Opening up BMJ peer review. BMJ (1999) 3.21
Doctors, unethical treatments, and turning a blind eye. BMJ (1989) 3.13
Development of the review quality instrument (RQI) for assessing peer reviews of manuscripts. J Clin Epidemiol (1999) 3.13
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
Reconfiguring acute hospital services. No easy answers, but there are principles we should follow. BMJ (1999) 3.07
Authorship is dying: long live contributorship. BMJ (1997) 3.07
Hamster health care. BMJ (2001) 3.06
Promoting research into peer review. BMJ (1994) 3.05
Rationing health care: moving the debate forward. BMJ (1996) 3.03
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res (2000) 3.01
GMC in the dock again. BMJ (1993) 2.99
Maintaining the integrity of the scientific record. BMJ (2001) 2.98
Altered relation of two collagen types in osteogenesis imperfecta. N Engl J Med (1977) 2.93
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (1988) 2.93
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91